Van beleggers
voor beleggers
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?
Home  /  Forum  /  Koffiekamer  /  Alibaba Health Info Tech Ltd

Ontvang nu dagelijks onze kooptips!

word abonnee

Koffiekamer« Terug naar discussie overzicht

Alibaba Health Info Tech Ltd

31 Posts
Pagina: 1 2 »» | Laatste | Omlaag ↓
  1. Sub!et 22 april 2020 11:29
    Ben op zoek naar gezellen om deze ticker te volgen
    $ALBHF
    Alibaba Health Info Tech Ltd

    Wel voor Long.
    Dochter van AliBaba ,verdeelt pharma oa via automaten en e-commerce
    Zeer solide, weinig info weliswaar.
    maar heeft de crisis zeer goed doorstaan.
    Met enkele institutionele beleggers.

    ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED is an investment holding company mainly engaged in the pharmaceutical e-commerce business. The Company provides e-commerce platform services.The e-commerce platform services include providing e-commerce platform maintenance related software services to Blue Cap Health Food merchants on Tmall.com and providing outsourced and value-added services to Tmall entities. In addition, the Company is also involved in the online and offline sale of self-operated healthcare products, the provision of the construction of a medical services network and other healthcare related services, as well as the provision of tracking services principally for the drug industry in the People's Republic of China (PRC).
  2. Sub!et 22 april 2020 11:32
    Institutional shareholders Top holders Movers 2.84%

    The Vanguard Group, Inc. AS OF 31 MAR 2020 138.44m 1.15%
    BlackRock Fund Advisors AS OF 01 APR 2020 66.62m 0.55%
    Credit Suisse Asset Management (Schweiz) AG AS OF 31 MAR 2020 29.74m 0.25%
    Norges Bank Investment Management AS OF 31 DEC 2019 26.46m 0.22%
    BlackRock Advisors (UK) Ltd. AS OF 02 APR 2020 20.49m 0.17%
    Fidelity Management & Research Co. LLC AS OF 29 FEB 2020 19.21m 0.16%
    Swedbank Robur Fonder AB AS OF 28 FEB 2020 14.45m 0.12%
    Candriam Belgium SA AS OF 29 FEB 2020 11.56m 0.10%
    Geode Capital Management LLC AS OF 16 APR 2020 9.06m 0.08%
    Ruffer (Asia) Ltd. AS OF 31 DEC 2019 6.80m 0.06%

    Data from 31 Dec 2019 - 16 Apr 2020
  15. Aquascaper 12 mei 2020 18:21
    Weinig nieuws maar de trend is leuk de afgelopen dagen :-)

    Hoop dat Novacyt weer een klein beetje omhoog krabbelt, want dan verkoop ik die en ga ik weer een plukje Alibaba Health bijkopen. Dit is een aandeel wat ik lekker lang laat staan.

    Geen echte updates van het bedrijf maar ze worden wel vaker benoemd:

    www.twst.com/news/healthcare-technolo...

    www.iol.co.za/business-report/belt-an...
  17. Sub!et 12 mei 2020 19:21
    ****The webinar series is the latest of several initiatives the Jack Ma and Alibaba Foundations have implemented to provide support in the global fight against Covid-19. Five webinars between China and Africa were held prior to this one. Over 3,000 African clinicians have participated in the six webinars.****

    Na de Chinese, en Australische, nu de Afrikaanse markt bespelen.
    Just my 2 cents.
  18. Sub!et 12 mei 2020 19:43
    DATE OF BOARD MEETING
    The board of directors (the ‘‘Board’’) of Alibaba Health Information Technology Limited (the ‘‘Company’’) hereby announces that a meeting of the Board will be held on Wednesday, May 27, 2020 for the purpose of considering and approving, inter alia, the final results of the Company and its subsidiaries for the year ended March 31, 2020 and the declaration of final dividend, if any.

    doc.irasia.com/listco/hk/alihealth/an...
  19. Sub!et 28 mei 2020 17:34

    De Cijfers :

    HIGHLIGHTS
    • For the year ended March 31, 2020 (the “Reporting Period”), the Group reported revenue and gross profit of RMB9,596.5 million and RMB2,231.4 million, representing a significant year-on-year growth of 88.3% and 67.6%, respectively. Such rapid growth in revenue and gross profit was mainly attributable to the rapid growth of the pharmaceutical direct business and the pharmaceutical e-commerce platform business during the year.
    • The Group’s loss for the year was RMB15.7 million, decreasing significantly by RMB76.1 million or 82.9% from a loss of RMB91.8 million for the preceding year. The Group’s adjusted net profit(note 1) increased by 114.8% to RMB261.4 million as compared to the preceding year. Net cash flows from operating activities also improved from RMB396.4 million to RMB583.6 million. The Group’s profitability continued to improve, laying a solid foundation for the Group to invest and make strategic deployments in businesses such as our prescription drugs, Internet healthcare and digital health businesses.

    doc.irasia.com/listco/hk/alihealth/an...
31 Posts
Pagina: 1 2 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Indices

AEX 874,02 -0,09%
EUR/USD 1,0702 +0,00%
FTSE 100 8.040,38 -0,06%
Germany40^ 18.086,70 -0,01%
Gold spot 2.317,64 +0,07%
NY-Nasdaq Composite 15.712,75 +0,10%

Stijgers

VIVORY...
+24,31%
ASMI
+10,99%
BESI
+4,08%
NX FIL...
+3,85%
TomTom
+3,80%

Dalers

ALLFUN...
-11,00%
ING
-5,96%
Flow T...
-2,94%
WDP
-2,89%
RELX
-2,04%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links

Meld u aan voor de dagelijkse Beursupdate

Dagelijks een update van het laatste beursnieuws en beleggingskansen in uw mailbox!